Company Overview and News
Pharma and biotech companies across the globe continued to expand and reshape their leadership teams with new hires this past week. BioSpace collected several announced leadership appointments, which includes new chief executive officers, new members to boards of directors and more.
Good afternoon. My name is Julie and I will be your conference operator today. At this time, I would like to welcome everyone to the Pulse Biosciences Investor Update Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session [Operator Instructions].
Atlantic Power Corporation (NYSE:AT) Q1 2018 Results Earnings Conference Call May 4, 2018 8:30 AM ET
Martin Midstream Partners LP (NASDAQ:MMLP) Q1 2018 Earnings Conference Call April 26, 2018 9:00 AM ET
Good morning, and welcome to the Atlantic Power Corporation's Fourth Quarter and Year End 2017 Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2017 Results Earnings Conference Call March 1, 2018 8:30 AM ET
Martin Midstream Partners LP. (NASDAQ:MMLP) Q4 2017 Earnings Conference Call February 15, 2018 9:00 AM ET
Good day, ladies and gentlemen, and welcome to the Second Quarter Fiscal 2018 pSivida Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today’s conference, Mr. Doug Sherk. Sir, you may begin.
It's 10 o' clock. Welcome to the Presentation of Skanska's Year-End Results for 2017. I am André Löfgren, and I'm heading up Investor Relations at Skanska. And the presentation is held here in Stockholm at our headquarters, but there's also lot of participants on the web and also over the phone. And you will all be able to ask questions after the presentation. And the presentation will be held by our CEO, Anders Danielsson and our CFO, Pete Wallin.
MANILA, Philippines — A modern, state-of-the-art central district will soon rise from what used to be the Matina Golf Club in Davao City.
Dynegy Inc. (DYN - Free Report) recently announced that it has agreed to sell the site of the former Brayton Point Power Station in Somerset, MA to Commercial Development Company, Inc. The company expects to conclude the deal by the end of 2017. However, the financial terms of the agreement were kept under wraps.
Good morning, and welcome to the Atlantic Power Corporation’s Third Quarter 2017 Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note that today's event is being recorded.
Good morning and thank you for standing by. Welcome to the Horizon Pharma Plc Third Quarter 2017 Earnings Conference Call. As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.
All right, good morning, everyone. It's 10 o'clock. Welcome to the presentation of Skanska's Nine Month Report for 2017. I am André Löfgren, heading up the Investor Relations at Skanska. And luckily, for you, guys, I'm not the one doing the presentation. It's going to be our CEO, Johan Karlström; and our CFO, Peter Wallin.
BASEL, Switzerland, Sept. 18, 2017 /PRNewswire/ -- Urovant Sciences, a global biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced the appointment of Keith A. Katkin as Chief Executive Officer.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...